Potential and challenges in application of physiologically based pharmacokinetic modeling in predicting diarrheal disease impact on oral drug pharmacokinetics
Drug Metabolism and Disposition · 2025
DOI: 10.1124/dmd.122.000964 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Cindy X Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, University of Washington, Seattle, Washington. Hauptthemen laut MEDLINE: Models, Biological, Diarrhea, Pharmacokinetics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health, NIAID.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, University of Washington, Seattle, Washington.
- Department of Pharmaceutics, University of Washington, Seattle, Washington. Electronic address: slarnold@uw.edu.
Förderung
- NIAID NIH HHS
- National Institutes of Health
- NIAID
Zitieren
APA
Zhang, C. X., & Arnold, S. L. M. (2025). Potential and challenges in application of physiologically based pharmacokinetic modeling in predicting diarrheal disease impact on oral drug pharmacokinetics. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.122.000964
Vancouver
Zhang CX, Arnold SLM. Potential and challenges in application of physiologically based pharmacokinetic modeling in predicting diarrheal disease impact on oral drug pharmacokinetics. Drug Metabolism and Disposition. 2025. doi:10.1124/dmd.122.000964
BibTeX
@article{Zhang2025,
author = {Zhang, Cindy X and Arnold, Samuel L M},
title = {Potential and challenges in application of physiologically based pharmacokinetic modeling in predicting diarrheal disease impact on oral drug pharmacokinetics},
journal = {Drug Metabolism and Disposition},
year = {2025},
doi = {10.1124/dmd.122.000964}
}
EUVIMED